Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
NexGel, Inc. stock logo
NXGL
NexGel
$2.41
-4.0%
$2.43
$2.00
$5.10
$19.21M0.5971,393 shs93,114 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.33
+3.1%
$4.72
$4.01
$9.33
$69.07M1.29188,735 shs69,063 shs
TELA Bio, Inc. stock logo
TELA
TELA Bio
$1.99
-1.0%
$1.65
$0.86
$4.82
$79.51M0.9204,458 shs60,625 shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.62
+6.6%
$1.20
$0.91
$1.80
$90.05M2.89100,547 shs339,100 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
NexGel, Inc. stock logo
NXGL
NexGel
-3.98%-11.40%-6.23%-14.84%+14.22%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.10%-5.66%-10.17%-5.66%-27.71%
TELA Bio, Inc. stock logo
TELA
TELA Bio
-1.00%-7.01%+23.60%+108.12%-58.19%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
+6.58%+28.57%+42.11%+52.83%+20.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
NexGel, Inc. stock logo
NXGL
NexGel
0.7072 of 5 stars
0.03.00.00.02.22.50.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.0646 of 5 stars
3.50.00.00.02.20.00.0
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.8628 of 5 stars
3.44.00.00.02.41.70.6
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
3.5421 of 5 stars
3.55.00.00.03.33.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
NexGel, Inc. stock logo
NXGL
NexGel
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$11.67169.44% Upside
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.75
Moderate Buy$7.25264.32% Upside
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
3.00
Buy$4.00146.91% Upside

Current Analyst Ratings Breakdown

Latest NXGL, TELA, SRTS, and VANI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
5/19/2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00 ➝ $4.00
4/16/2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00 ➝ $4.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
NexGel, Inc. stock logo
NXGL
NexGel
$8.69M2.12N/AN/A$0.90 per share2.68
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.70$0.45 per share9.72$3.41 per share1.27
TELA Bio, Inc. stock logo
TELA
TELA Bio
$69.30M1.14N/AN/A$0.72 per share2.76
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/A$0.30 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
NexGel, Inc. stock logo
NXGL
NexGel
-$3.28M-$0.45N/AN/A-30.80%-54.95%-27.84%8/18/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1043.3018.83N/A4.56%3.34%3.00%8/6/2025 (Estimated)
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$37.84M-$1.41N/AN/AN/A-61.00%-402.45%-62.73%8/11/2025 (Estimated)
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$23.49M-$0.43N/AN/AN/AN/A-133.07%-56.50%8/12/2025 (Estimated)

Latest NXGL, TELA, SRTS, and VANI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2025Q2 2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.09N/AN/AN/AN/AN/A
8/11/2025Q2 2025
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$0.18N/AN/AN/A$20.67 millionN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/13/2025Q1 2025
NexGel, Inc. stock logo
NXGL
NexGel
-$0.10-$0.09+$0.01-$0.09$2.73 million$2.81 million
5/13/2025Q1 2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.10-$0.11-$0.01-$0.11N/AN/A
5/8/2025Q1 2025
TELA Bio, Inc. stock logo
TELA
TELA Bio
-$0.21-$0.25-$0.04-$0.25$17.35 million$18.52 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
NexGel, Inc. stock logo
NXGL
NexGel
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
TELA Bio, Inc. stock logo
TELA
TELA Bio
N/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
NexGel, Inc. stock logo
NXGL
NexGel
0.15
1.88
1.15
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74
TELA Bio, Inc. stock logo
TELA
TELA Bio
2.28
4.22
3.40
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/A
2.40
2.40

Institutional Ownership

CompanyInstitutional Ownership
NexGel, Inc. stock logo
NXGL
NexGel
2.21%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
TELA Bio, Inc. stock logo
TELA
TELA Bio
94.35%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
6.78%

Insider Ownership

CompanyInsider Ownership
NexGel, Inc. stock logo
NXGL
NexGel
20.55%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
TELA Bio, Inc. stock logo
TELA
TELA Bio
4.70%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
46.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
NexGel, Inc. stock logo
NXGL
NexGel
107.65 million6.08 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
TELA Bio, Inc. stock logo
TELA
TELA Bio
12039.56 million37.70 millionOptionable
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2059.24 million31.76 millionOptionable

Recent News About These Companies

Companies To Watch: Vivani Medical
Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs

New MarketBeat Followers Over Time

Media Sentiment Over Time

NexGel stock logo

NexGel NASDAQ:NXGL

$2.41 -0.10 (-3.98%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$2.43 +0.02 (+0.79%)
As of 07/16/2025 05:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.33 +0.13 (+3.10%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$4.38 +0.05 (+1.18%)
As of 07/16/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

TELA Bio stock logo

TELA Bio NASDAQ:TELA

$1.99 -0.02 (-1.00%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$2.04 +0.05 (+2.46%)
As of 07/16/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Vivani Medical stock logo

Vivani Medical NASDAQ:VANI

$1.62 +0.10 (+6.58%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$1.66 +0.04 (+2.78%)
As of 07/16/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.